The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura Dawson, MD, FASTRO, Chair of the ASTRO Board of Directors, in response to the 2022 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules announced by the Centers for Medicare and Medicaid Services (CMS)

Getty Images


November 3, 2021 — The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura Dawson, MD, FASTRO, Chair of the ASTRO Board of Directors, in response to the 2022 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules announced by the Centers for Medicare and Medicaid Services (CMS):

"On behalf of ASTRO’s 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating cancer patients with radiation therapy, we are deeply disappointed that the Biden administration failed to reverse excessive cuts in the Medicare fee schedules that will strip significant resources from radiation oncology and undermine the administration's own goals to bring an end to cancer.

These cuts will endanger patient access to cancer care. Treatment facilities may be forced to cut services or close, which will exacerbate health disparities. Moreover, the planned January 1, 2022, start date for the hundreds of radiation oncology facilities required to participate in the Radiation Oncology Model (RO Model) is extremely challenging. While we appreciate some new flexibilities to account for the public health emergency, payment cuts are the last thing practices need as they continue to weather the pandemic and care for growing numbers of patients with advanced-stage cancers due to pandemic-related cancer screening delays. We will continue to engage with CMS on ways to improve quality without forcing onerous reporting requirements.

ASTRO appreciates the more-than 100 members of Congress who wrote CMS opposing these cuts, and we intend to work with these radiation oncology Congressional champions on a legislative solution to address the Medicare cuts before the year ends. We will continue our longstanding push toward value-based care in radiation oncology that will improve outcomes for people with cancer."

ASTRO's health policy experts are currently completing an in-depth analysis of the model. 

For more information: www.astro.org

Related CMS Content:

Senators and representatives unite to call on CMS to protect patient access to high-quality radiation treatments

ASTRO Submits RO Model Comment Letters to CMS

ASTRO Advocacy Day Draws Record Number of Advocates Seeking Change


Related Content

News | Stereotactic Body Radiation Therapy (SBRT) | American Society for Radiation Oncology

Sept. 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival ...

Time October 15, 2025
arrow
News | Proton Therapy

Sept. 28, 2025 — Leo Cancer Care has launched Grace, the company's upright photon therapy system. Grace is named after ...

Time October 03, 2025
arrow
News | Prostate Cancer

Sept. 30, 2025 – EDAP TMS's non-invasive, nonsurgical treatment option, Focal One Robotic HIFU, was featured on national ...

Time September 30, 2025
arrow
News | Radiation Therapy | American Society for Radiation Oncology (ASTRO)

Sept. 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation ...

Time September 30, 2025
arrow
News | Radiation Therapy

Sept. 26, 2025 – Accuray Inc. has introduced the Accuray Stellar* solution. Initially for the U.S. market, the new ...

Time September 29, 2025
arrow
News | Computed Tomography (CT)

Sept. 26, 2025 — At the American Society for Radiation Oncology (ASTRO) 2025 annual meeting in San Francisco, Calif ...

Time September 29, 2025
arrow
News | Lung Imaging

Sept. 26, 2025 ― Researchers from the University of Texas MD Anderson Cancer Center will present new data at the ...

Time September 29, 2025
arrow
News | ASTRO

Sept. 26, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time September 29, 2025
arrow
News | Radiation Therapy

Sept. 25, 2025 — GE HealthCare has announced updates to Intelligent Radiation Therapy (iRT), a new version of the ...

Time September 25, 2025
arrow
News | Proton Therapy

Sept. 15, 2025 — Mevion Medical Systems announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

Time September 18, 2025
arrow
Subscribe Now